Abstract:Objective: To investigate the effect of circulating exosomes (EXO) on T cell function in patients with sepsis. Methods: Plasma EXO were obtained by ultracentrifugation from 10 patients with sepsis admitted to the emergency intensive care unit of Guangdong Provincial People's Hospital Affiliated to Southern Medical University. Transmission electron microscopy observation, nanoparticle tracking analysis (NTA), and Western blotting were used to detect EXO markers to identify their characteristics. Furthermore, peripheral blood mononuclear cells (PBMC) were isolated from the peripheral blood of 5 healthy volunteers, primary T cells were sorted by magnetic beads and expanded in vitro. After 24 hours of intervention with different doses (0, 1, 2.5, 5, 10 mg/L) of circulating EXO in patients with sepsis, T-cell activity was assessed using a cell counting kit-8 (CCK-8). The expression of T cell activation indicators CD69 and CD25 were observed using flow cytometry. Additional evaluations were performed on immunosuppressive indicators including the expression of programmed cell death 1 (PD-1) in CD4+ T cells and the proportion of regulatory T cell (Treg). Results: The identification results confirmed that the successful isolation of EXO from the plasma of sepsis patients. The expression level of circulating EXO in sepsis patients was higher than that in healthy control group (mg/L: 48.78±5.14 vs. 22.18±2.25, P < 0.01). After 24 hours of intervention with 5 mg/L of plasma EXO from sepsis patients, T cells activity began to show suppression [(85.84±0.56)% vs. (100.00±0.00)%, P < 0.05]. As the dosage increased, after 24 hours of intervention with 10 mg/L of EXO, T cells activity was significantly suppressed [(72.44±2.36)% vs. (100.00±0.00)%, P < 0.01]. Compared with the healthy control group, after T cells intervention with plasma EXO from sepsis patients, the expression of early activation marker CD69 was significantly reduced [(52.87±1.29)% vs. (67.13±3.56)%, P < 0.05]. Meanwhile, there was an upregulation of PD-1 expression in T cells [(57.73±3.06)% vs. (32.07±0.22)%, P < 0.01] and an increase in the proportion of Treg [(54.67±1.19)% vs. (24.60±3.51)%, P < 0.01]. However, the expression of the late activation marker CD25 remained stable [(84.77±3.44)% vs. (85.93±2.32)%, P > 0.05]. Conclusions: Circulating EXO in sepsis patients induce T cell dysfunction, which may be a novel mechanism lead to immunosuppression in sepsis.

Complement C3 depletion links to the expansion of regulatory T cells and compromises T-cell immunity in human abdominal sepsis: A prospective pilot study

Complement C3 Depletion Compromises the Outcomes of Human Abdominal Sepsis: a Link to the Expansion of Regulatory T Cells

Complement Depletion Deteriorates Clinical Outcomes of Severe Abdominal Sepsis: A Conspirator of Infection and Coagulopathy in Crime?

Effect of Interleukin-36β on Activating Autophagy of CD4+CD25+ Regulatory T Cells and Its Immune Regulation in Sepsis.

Exogenous C3 Protein Enhances the Adaptive Immune Response to Polymicrobial Sepsis Through Down-Regulation of Regulatory T Cells.

Interleukin‐38 protects against sepsis by augmenting immunosuppressive activity of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells

Exogenous C3 Postpones Complement Exhaustion and Confers Organ Protection in Murine Sepsis

Changes in Early T-Cell Subsets and Their Impact on Prognosis in Patients with Sepsis: A Single-Center Retrospective Study

Deregulation of T cell response in sepsis.

The effect of human complement C3 protein applied at different times in treatment of polymicrobial sepsis

Septic Macrophages Induce T Cells Immunosuppression in a Cell-Cell Contact Manner with the Involvement of CR3

High Circulating CD39+ Regulatory T Cells Predict Poor Survival for Sepsis Patients

[Effect of circulating exosomes in patients with sepsis on T cell function]

Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study

The Effect of Immunomodulatory Therapy on CD4+CD25+ Tregs in Peripheral Blood of Patients with Sepsis

Increased Proportion of CD4+CD25+Foxp3+ Regulatory T Cells During Early-Stage Sepsis in ICU Patients

Complement component consumption in sepsis correlates better with hemostatic system parameters than with inflammatory biomarkers

CD71+ Erythroid Cell Expansion in Adult Sepsis: Potential Causes and Role in Prognosis and Nosocomial Infection Prediction

ITGB2 and ICAM3 Predict Increased Survival of Sepsis with Decreased Intercellular Communication in Cytotoxic CD8+ T- Cells

Clinical Correlations of Peripheral Blood Lymphocyte Populations in Sepsis

Decoding the potential role of regulatory T cells in sepsis‐induced immunosuppression